
Synflorix - European Medicines Agency (EMA)
Synflorix is a vaccine that contains parts of the bacterium Streptococcus pneumoniae , also called pneumococcus). It is used to protect infants and children aged between 6 weeks and 5 years against invasive disease, pneumonia (infection of the lungs) and acute otitis media (infection of the middle ear) caused by S. pneumoniae.
SYNFLORIX [pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed] is a 10-valent pneumococcal polysaccharide conjugate vaccine using protein D derived from Non-Typeable Haemophilus influenzae as a carrier
Synflorix™, GlaxoSmithKline’s pneumococcal vaccine, receives ... - GSK
GlaxoSmithKline (GSK) today received European Commission authorisation for Synflorix™, a paediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumonia, as well as middle ear infections. In Europe, approximately one in three cases of serious pneumococcal disease in young children ...
Synflorix: Uses, Side Effects, Benefits/Risks | Drugs.com
Synflorix is a vaccine that contains parts of the bacterium Streptococcus pneumoniae (S. pneumoniae, also called pneumococcus). It is used to protect infants and children aged between 6 weeks and 5 years against invasive disease, pneumonia (infection of the lungs) and acute otitis media (infection of the middle ear) caused by S. pneumoniae.
技术分析与接种之道:国产肺炎13价结合疫苗 - 健康界
2020年4月14日 · 史克公司的10价结合疫苗Synflorix,于2009年在欧盟上市,但没有在中国上市,所以没有中文商品名。 Synflorix作为后来者,当然覆盖了沛儿预防的7个肺炎球菌型别,还增加了1型、5型和7F型。
second year of life in children primed with 3 doses of SYNFLORIX, lower antibody geometric mean concentration (GMC) and opsonophagocytic assay geometric mean titre (OPA GMT) were observed for one pneumococcal serotype (18 C).
The use of Synflorix should be determined on the basis of official recommendations taking into consideration the impact on pneumococcal diseases in different age groups as well as the variability of
SYNFLORIX - MesVaccins
Synflorix est indiqué chez l’enfant âgé de 6 semaines à 5 ans (c’est-à-dire jusqu’au jour du 5 ème anniversaire). Les enfants doivent recevoir le schéma de vaccination Synflorix adapté à leur âge déterminé au moment de l’initiation de la primovaccination (voir rubrique Posologie).
GSK肺炎疫苗Synflorix新适应症获欧盟批准 - 行业观察
2013年12月9日 · Synflorix是一种10价疫苗,与目前市场上的7价疫苗相比,Synflorix包含的其他3种血清型(1、5与7F型),使其能预防更多的 IPD。 欧洲部分地区5岁以下儿童感染IPD的病历中,约90%是由本品所包含的这10种血清型肺炎球菌引起的。
Synflorix Vaccine: View Uses, Side Effects, Price and Substitutes
2025年3月28日 · Synflorix Vaccine provides protection against diseases caused by ten different strains of Streptococcus pneumoniae bacteria. It is usually given as an injection into the muscle (intramuscularly) of the upper thigh or upper arm, by a doctor or nurse.